Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 1
1997 1
1998 1
1999 5
2000 3
2001 5
2002 1
2003 2
2004 2
2005 1
2006 6
2007 4
2008 9
2009 12
2010 10
2011 3
2012 3
2013 2
2014 2
2015 4
2016 5
2017 4
2018 2
2019 4
2020 4
2021 13
2022 10
2023 14
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
[Localized prostate cancer].
Sailer VW, Perner S, Wild P, Köllermann J. Sailer VW, et al. Among authors: kollermann j. Pathologe. 2021 Nov;42(6):603-616. doi: 10.1007/s00292-021-00997-8. Epub 2021 Oct 14. Pathologe. 2021. PMID: 34648048 German.
[Metastatic castration-resistant prostate cancer].
Henriques V, Wenzel M, Demes MC, Köllermann J. Henriques V, et al. Among authors: kollermann j. Pathologe. 2021 Jul;42(4):431-441. doi: 10.1007/s00292-021-00956-3. Epub 2021 Jun 25. Pathologe. 2021. PMID: 34170384 Review. German.
Epigenetic profiling of prostate cancer reveals potential prognostic signatures.
Bernatz S, Reddin IG, Fenton TR, Vogl TJ, Wild PJ, Köllermann J, Mandel P, Wenzel M, Hoeh B, Mahmoudi S, Koch V, Grünewald LD, Hammerstingl R, Döring C, Harter PN, Weber KJ. Bernatz S, et al. Among authors: kollermann j. J Cancer Res Clin Oncol. 2024 Aug 24;150(8):396. doi: 10.1007/s00432-024-05921-0. J Cancer Res Clin Oncol. 2024. PMID: 39180680 Free PMC article.
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer.
Gui F, Jiang B, Jiang J, He Z, Tsujino T, Takai T, Arai S, Pana C, Köllermann J, Bradshaw GA, Eisert R, Kalocsay M, Fassl A, Balk SP, Kibel AS, Jia L. Gui F, et al. Among authors: kollermann j. bioRxiv [Preprint]. 2024 Nov 7:2024.07.09.602803. doi: 10.1101/2024.07.09.602803. bioRxiv. 2024. PMID: 39026842 Free PMC article. Preprint.
[Fluorescence confocal microscopy-complete digitization of pathology].
Loth AG, Fassl A, Chun FKH, Köllermann J, Hartmann S, Gretser S, Ziegler PK, Flinner N, Schulze F, Wild PJ, Kinzler MN. Loth AG, et al. Among authors: kollermann j. Pathologie (Heidelb). 2024 May;45(3):211-217. doi: 10.1007/s00292-024-01311-y. Epub 2024 Mar 6. Pathologie (Heidelb). 2024. PMID: 38446176 Free PMC article. German.
Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany.
Mandel P, Hoeh B, Humke C, Doering C, Wenzel M, Cano Garcia C, Fuhr N, Koll F, Fassl A, Tilki D, Steuber T, Faull I, Jeroch J, Ebner S, Schmitt C, Reis H, Köllermann J, Kokkaliaris KD, Demes MC, Chun FKH, Wild PJ. Mandel P, et al. Among authors: kollermann j. Eur Urol Focus. 2024 Mar;10(2):339-345. doi: 10.1016/j.euf.2024.02.007. Epub 2024 Mar 15. Eur Urol Focus. 2024. PMID: 38493067 Free article.
[Focal therapy of prostate cancer].
Ganzer R, Franiel T, Köllermann J, Kuru T, Baumunk D, Blana A, Hadaschik B, von Hardenberg J, Henkel T, Köhrmann KU, Liehr UB, Machtens S, Roosen A, Salomon G, Schlemmer HP, Sentker L, Wendler J, Witzsch U, Schostak M. Ganzer R, et al. Among authors: kollermann j. Urologe A. 2017 Oct;56(10):1335-1346. doi: 10.1007/s00120-017-0488-z. Urologe A. 2017. PMID: 28856386 German.
124 results